Perhaps patient 8 will be part of C/5 seeing C/4 is safe and seemingly not producing much viral response
They've met all criteria and approval of FDA commitee which they have to be part of being new innovation
Cant see why not.
Why delay any further
- Forums
- ASX - By Stock
- BLT
- Ann: Chairman's Address to Shareholders
Ann: Chairman's Address to Shareholders, page-46
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online